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1. Introduction 
Parkinson disease (PD) is a neurodegenerative disorder not only with motor symptoms, 
including resting tremor, rigidity, bradykinesia and postural instability, but also with non-
motor symptoms, including autonomic disturbance, sleep disturbance and depression. Due 
to the lack of objective biomarkers like the blood glucose level for diabetes mellitus, severity 
of parkinsonism has been evaluated by using the symptom-based Unified Parkinson Disease 
Rating Scale (UPDRS) (Martinez-Martin et al., 1994) that covers the various aspects of 
symptoms in patients with PD. Although the UPDRS is the standard method for the 
assessment of parkinsonism and the evaluation of drug effects, the scoring is not free from 
inter-rater variance or the fluctuation of the symptoms.  
Wearable accelerometers enable long-term recording of patient’s movement during 
activities of daily living, and hence might be a suitable device for quantitative assessment of 
the disease severity and progression. Alterations in locomotor-activity levels and 
disturbances in rest-activity rhythms have long been recognized as integral signs of major 
psychiatric and neurological disorders (Teicher, 1995; Witting et al., 1990). Improvement of 
ambulatory activity monitors (actigraph) has enabled precise calibration and storage of 
thousands of activity measurements acquired at predetermined times, hence enabled long-
term recording of patient’s movement during ordinary daily living (Katayama, 2001; Korte 
et al., 2004; Mormont et al., 2000; Okawa et al., 1995; Teicher, 1995; Tuisku et al., 2003; van 
Someren et al., 1996). It has been demonstrated that use of these devices is useful for the 
quantitative estimation of human behavior properties in normal subjects and patients with a 
variety of diseases, including depression, pain syndrome, and PD (Jean-Louis et al., 2000; 
Korszun et al., 2002; Nakamura et al., 2007; Ohashi et al., 2003; Pan et al., 2007; van Someren 
et al., 1993; 1998; 2006). However, because the pattern of daily activity greatly influences the 
recording with accelerometers, recorded activity levels may not adequately reflect the 
disease severity (Fig 1). Therefore, reliable analytical methods of the body acceleration 
signal free from the level of activity are required to describe the characteristics of body 
activity during daily living. Recently, fractal analysis was shown to be a robust tool to 
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disclose hidden auto-correlation patterns in biological data, such as heartbeat and limb 
movement (Ohashi et al., 2003; Pan et al., 2007; Peng et al., 1995; Sekine et al., 2004; Struzik et 
al., 2006). Power-law auto-correlation exponents for local maxima and minima of 
fluctuations of locomotor activity would be the most useful for our purpose, as they 
represent the level of persistency of movement patterns (Ohashi et al., 2003; Pan et al., 2007). 
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Fig. 1. Examples of 24 h actigraph recording. (left) Each vertical bar indicates activity counts 
per min. Sleep time is indicated in blue. Patients with approximately the same severity show 
different activity patterns and the activity counts (right: mean ± S.D.). UPDRS total/Part III. 
In this review, we show how we can extract hidden autocorrelation patterns reflecting the 
severity of parkinsonism from the actigraph recording of patients’ activity, and demonstrate 
that the analysis using power-law exponents is useful for the evaluation of effects of therapy 
on motor and non-motor symptoms of parkinsonism. 
2. Analytical method of the motionlogger recordings for power-law auto-
correlation exponents 
We analyzed patients’ physical activity records collected by an actigraph device using 
power-law exponents probing temporal auto-correlation of the activity counts. The power-
law exponent for local maxima most sensitively and reliably reflects disability without being 
influenced by the presence of tremor or the patterns of daily living (Pan et al., 2007). 
To examine temporal auto-correlation of the physical activity time series (i.e., dynamic 
aspects of physical activity), we used an extended, random-walk analysis, the detrended 
fluctuation analysis (DFA) (Peng et al., 1995), with a modification (Ohashi et al., 2003) for 
various “real-world” signals including activity time series. Briefly, a daytime physical 
activity time series was integrated, as in DFA, and wavelets with different time scales (S) 
were slid along the time series and correlated with the data to obtain the wavelet coefficients 
(W(S)) at each point. The third derivative of the Gaussian function was used as the so-called 
“mother wavelet”: 
Ψ(t) = t(3-t2)e-0.5t
2
,2 
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where t is time. This is equivalent to using the Gaussian second derivative (so-called 
“Mexican hat”) wavelet to examine the raw signals (Fig. 2), though the integration approach 
automatically removes the local mean and the local linear trend, as in DFA. By changing the 
scale of the wavelet, this “hat-shaped” template dilates or contracts in time, probing 
transient increases or decreases in activity records in different time scales. The transient 
increases (low-high-low activity patterns) yield local maxima of the wavelet coefficients at 
their time points, while the decreases (high-low-high activity patterns) yield local minima of 
the wavelet coefficients (see Fig. 2). Next, the squared wavelet coefficients at the local 
maxima or minima were averaged for all the available days. As the coefficient gives the 
magnitude of local fluctuations matching the shape of (t) with different time scales, the 
squared W(S) was used, again as in DFA. Finally, the power-law exponent (α) was obtained 
separately for local maxima and minima as the slope of a straight line fit in the double-
logarithmic plot of S vs. W(S)2. This method yields the same α–values as does DFA (Ohashi 
et al., 2003), but separately for periods with higher and lower activity levels. The power-law 
(scaling) exponent, α, reflects the probability of a simultaneous increase or decrease in the 
variability at two distant points in time in the time series, applied to all distances up to long-
range time scales, thereby probing the nature of “switching'” patterns between high and low 
values in a statistical sense. Larger power-law exponents indicate positive temporal auto-
correlation or persistency in the increase or decrease, and lower values correspond to 
negative auto-correlation or anti-persistency (Ohashi et al., 2003). 
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Fig. 2. Conceptual explanation of the method to obtain power-law exponents for local 
maxima and minima. (top) Various widths of hat-shaped wavelets are slid along the data to 
detect local minima (middle) and local maxima (bottom) of the wavelet coefficients. Note that 
the local minima and maxima appear at the transient decreases and increases of the activity, 
respectively. The power-law exponents are calculated from the slope of the log-log plot of 
squared wavelet coefficients vs. the scale for local minima and maxima. In the actual 
analysis, we used an integrated, rather than raw, time series and (t), i.e., the derivative of 
the “hat-shaped” wavelet. This yields the same power-law exponents as those obtained by 
the DFA method for the same local maxima and minima as obtained in this figure. 
Reprinted with permission from (Pan et al., 2007). 
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This method enables to evaluate relationships between time scales and magnitudes of 
fluctuation within each time scale, eliminating non-stationarity in the input data (i.e., changes 
in the baseline and trends within the data windows at different scales) that could affect 
calculation of the magnitudes of fluctuation. Therefore, this approach is suitable for the 
analysis of the long-term data collected in ambulatory settings (Pan et al., 2007).  
3. Quantitative analysis of parkinsonism using power-law auto-correlation 
exponents 
The data acquired during awake-time and sleep-time were separated with Action-W, 
Version 2 (Ambulatory Monitors Inc., Ardsley, NY) (Fig. 1) and the data during awake-time 
were used for analyses. Average wavelet coefficients for local maxima and minima of the 
severe and mild groups provided straight lines in the range of 8-35 min (Fig. 3A), indicative 
of very robust α-values. When the mean α-values for local maxima and minima were 
compared, they found a significantly lower α-value for local maxima in the mild group than 
in the severe group (Fig. 3B). All the patients (13 male and 9 female patients with Parkinson 
disease) in both the severe (Hoeh-Yahl score > 3.0; n=9)) and mild groups (H-Y score ≦ 3.0; 
n=10)) showed significantly lower α-values for local maxima on good-condition (GC) days 
than on bad-condition (BC) days that were classified according to diary scores, whereas 
there was no significant difference in the mean α-values for local minima (Fig. 3C).  
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Fig. 3. Local maxima and minima of fluctuation of physical activity. (A) Average wavelet 
coefficients, as a function of the wavelet scale, for local maxima and minima. The slopes are 
power-law exponents, . (B) Comparisons of the meanfor the severe and the mild groups, 
(C) for BC and GC days and for individual patients, and (D) for days before and after 
antiparkinsonism medication and for each patient. *: P < 0.05, **: P < 0.01, and ***: P < 0.001. 
Reprinted with permission from (Pan et al., 2007). 
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When the effects of medication were examined, we found that all the patients who did not 
take any medication at the time of enrolement (n=6) showed lower α-values for local 
maxima on days more than three weeks after they received clinically effective anti-
parkinsonism medication than on those before (Fig. 3D). Although presence of tremor 
significantly increased the activity counts in the arms with tremor as compared with those 
without tremor (Fig. 4A), power-law scaling of the records from arms with tremor showed a 
linear correlation between log S and log W(S)2 in the range of 8 to 35 min (Fig. 4B) and α-
values for local maxima were the same between the arms with tremor and those without 
tremor (Fig. 4B) with significantly higher α-values in patient arms than in control arms (Fig. 
4C)  
 
 
Fig. 4. Effects of tremor on actigraph counts and the power-law exponents. (A) Daily profiles 
of physical activity for the arm affected with tremor and that without tremor of a patient 
with unilaterally predominant parkinsonism with continuous tremor on one side. (B) 
Average wavelet coefficients for local maxima among arms with tremor (tremor) and 
without tremor (no tremor) of 6 patients with tremor, 26 arms of 13 patients without tremor 
(without tremor) and 20 arms of 10 control subjects (control). (C) The power-law exponents 
for local maxima and minima. *: P < 0. 05. Reprinted with permission from (Pan et al., 2007). 
Larger power-law exponents (α) indicate positive temporal auto-correlation, or persistency, 
in the increase or decrease in the variability of activity at two distant points in time in the 
time series, and lower values correspond to negative auto-correlation or anti-persistency 
(Ohashi et al., 2003). In other words, a lower α for local maxima or minima of activity 
records reflects more frequent switching behavior from low to high or high to low physical 
activity, respectively, and the switching behavior from lower to higher activity levels is 
considered to be related to akinesia in patients with parkinsonism. We found lower α-values 
for local maxima during GC days than during BC days, in the mild group than in the severe 
group, and before medication than after medication. Thus, these results demonstrate that 
the power-law analyses accurately describe the well known phenomenon that under these 
conditions patients switch their physical activity from lower to higher levels more easily, in 
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other words they exhibit milder akinesia, when the parkinsonism is mild than when it is 
severe. It is worthy to note that lower α-values for local maxima were obtained for all the 
patients after medication than before, and when in good condition than in bad condition 
(Fig. 3C, D), thereby providing a temporal profile of parkinsonism in each individual 
patient. 
These results thus suggest that analysis of power-law temporal auto-correlation of physical 
activity time series using the bi-directional extension (Ohashi et al., 2003) is applicable to 
patients with parkinsonism for the evaluation of motor dysfunction irrespective of the 
presence of tremor and may provide useful objective data necessary for the control of drug 
dosage in the out-patient clinic and also for the evaluation of new drugs for parkinsonism 
(Pan et al., 2007). 
4. Evaluation of effects of traditional Chinese medicine on parkinsonian 
symptoms 
Conventional antiparkinsonism drugs effectively ameliorate the symptoms of patients with 
PD during the initial several years of onset, but become increasingly less effective and 
induce motor fluctuations including wearing-off, on-off, dopa-induced dyskinesia, and 
agonist-induced sleep attack (Arnulf et al., 2002; Comella, 2002; Hobson et al., 2002; Ondo et 
al., 2001; Pahwa et al., 2006). PD patients not infrequently suffer from non-motor symptoms, 
such as neuropsychiatric symptoms, autonomic symptoms, gastrointestinal symptoms, 
sensory symptoms, non-motor fluctuations (autonomic symptoms, cognitive or psychiatric 
symptoms, sensory symptoms including pain), fatigue, and sleep disturbance (Chaudhuri& 
Schapira, 2009; Miyasaki et al., 2006; Park& Stacy, 2009), and these non-motor symptoms 
may be intrinsic to the disease pathology or may be the result of treatment with 
dopaminergic agents. Several studies have established that the non-motor symptoms of PD 
are common, occur across all stages of PD, and are a key determinant of quality of life 
(Chaudhuri& Schapira, 2009). 
Herbal remedies have a long history of use (particularly in East Asian countries) for 
alleviating various symptoms and have been increasingly used as alternative medicines 
worldwide, including the United States (De Smet, 2002). Traditional Chinese medicines 
(TCM) ameliorate various symptoms, particularly the ageing-related symptoms, and hence 
are likely to be beneficial for chronic diseases such as PD (Iwasaki et al., 2004; 2005a; 2005b). 
Good compliance for long-term use with few side effects may be another merit of TCM 
suitable for patients with PD (Lian& Luo, 2007; Zhao et al., 2007).   
In order to evaluate the effects of TCM on symptoms of parkinsonism, we evaluated the 
effects of Zeng-xiao An-shen Zhi-chan 2 (ZAZ2) on patients with PD using this method 
together with conventional scales for parkinsonism (Pan et al., 2011a). ZAZ2 granule is 
made up of 14 kinds of herbs; Uncaria rhynchophylla 10 g, Rehmanniae radix 10 g, Cornus 
officinalis 8 g, Asnaragus cochinchinensic 10 g, Paeonia lactiflora 10 g, Desertliving cistanche 10 g, 
Puerariae radix 10 g, Arisaema consanguineum Schott 10 g, Salviae Miltiorrhizae radix 10 g, 
Acorus tatarinowii 10 g, Curcuma longa Linn 12 g, Morindae officinalis radix 10 g, Rhizoma 
gastrodiae 10 g, andRhizoma chuanxiong 10 g. One hundred and fifteen patients with 
idiopathic PD took 8 g of either ZAZ2 granule or placebo granule that was not distinguished 
by appearance or taste for 13 weeks. Patients were randomly assigned to the ZAZ2 group  
(n=59) or placebo group (n=56). There was no difference in the mean age, gender ratio or 
disease duration between the ZAZ2 and placebo groups, and the post hoc test revealed no 
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significant baseline (week 0) differences in UPDRS scores, Hoehn & Yahr stages, mean 
counts, power-law temporal exponent α values, or in the dosage of antiparkinonian drugs 
between the two groups. All the patients were evaluated at week 0, week 1, and week 13 for 
the actigraph recording, UPDRS and Secondary Symptom Score, which is conventionally 
used in China to evaluate the effects of antiparkinsonism drugs and consists of 8 parts, 
including the assessments of non-fluent speech, vertigo, insomnia/nightmares, headache, 
sweating or night sweats, tiredness, sense of cold, and dysuria (Long, 1992). The awake-time 
and sleep-time actigraph data were used separately for the power-law temporal analyses. 
 
 
Fig. 5. Effects of TCM and placebo granules on actigraph recondings. (A) Counts of physical 
activity (mean ± S.D.). (B) Average wavelet coefficients, as a function of the wavelet scale for 
awake-time and sleep-time. The slopes are power-law exponents α. (C) Power-law 
exponents α (mean ± S.D.). *: P < 0.05, **: P < 0.01. (Pan et al., 2011a) 
The local power-law exponent α values during both awake-time and sleep-time were 
significantly decreased after taking ZAZ2 granule, but not after taking placebo granule 
(Table 1, Fig 5). The average wavelet coefficients exhibited linear relationships in the range 
of scales from 8 min to 35 min both for the ZAZ2 and placebo groups (Fig. 5B). The local 
power-law exponent α values during both awake-time and sleep-time were significantly 
decreased both week 1 and 13 in the ZAZ2 group, but not in the placebo group (Table 1 and 
Fig 5C, P<0.01; Bonferroni test). The beneficial effects of ZAZ2 were shown with UPDRS 
scores, as well; significant and persistent improvements were found in the scores of Part II, 
Part II + Part III, and Part IV (Table 1). These scores at week 13 were significantly different 
between the ZAZ2 group and the placebo group. As the exploratory outcome of this study, 
most of the secondary symptoms were improved after taking ZAZ2 granule, whereas only a 
few symptoms were transiently improved in the placebo group (Table 2). 
We evaluated the beneficial effects of TCM specifically on sleep disturbance of patients with 
parkinsonism. We used placebo-controlled, randomized study design, in which 48 patients 
www.intechopen.com
 
Diagnostics and Rehabilitation of Parkinson's Disease 
 
232 
Week 0 Week 1 Week 13 Week 0 Week 1 Week 13
UPDRS total score 46.6 ± 16.3 44.7 ± 15.3 45.9 ± 18.1 46.3 ± 17.1 37.1 ± 11.2*## 40.7 ± 15.1* #
UPDRS I 2.5 ± 0.7 2.3 ± 1.1 2.4 ± 1.2 2.6 ± 0.8 2.1 ± 0.7* 2.3 ± 0.9
UPDRS II 15.7 ± 9.3  14.8 ± 11.2 15.3 ± 11.6  15.9 ± 11.3 12.5 ± 4.6*# 13.4 ± 9.8*#
UPDRS III 25.5 ± 12.9 23.8 ± 10.6* 24.9 ± 12.7 25.4 ± 10.1 19.3 ± 9.8*# 21.6 ± 10.4*
UPDRS IV  3.1 ± 1.1 2.9 ± 1.6 3.0 ± 1.4 3.2 ± 1.4 2.6 ± 0.8* # 2.7±1.3*#
Awake-time (counts/min) 98.5 ± 14.1 102.6 ± 18.9 100.7 ± 16.9 99.8 ± 17.8 126.7 ± 13.4*## 118.4 ± 11.8*##
Sleep-time (counts/min) 42.9 ± 17.1 38.8 ± 15.6* 40.1 ± 14.8 43.2 ± 11.6 35.6 ± 13.6* # 32.8 ± 13.6* #
α(awake-time) 0.97 ± 0.21 0.95 ± 0.28 0.96 ± 0.18 0.97 ± 0.24 0.88 ± 0.21* # 0.86 ± 0.19* ##
α(sleep-time) 1.19 ± 0.28 1.16 ± 0.27 1.15 ± 0.29 1.18 ± 0.26 1.04 ± 0.22* # 1.02 ± 0.18* ##
Data presented are mean ± SD.*:P < 0.05; **:P < 0.01 compared to week 0 (Repeated-measure ANOVAs).
#:P < 0.05;  ##:P < 0.01 compared to placebo (Bonferroni test). UPDRS: Unified Parkinson's Disease Rating Scale.
 : power-law exponent.
TCM′n = 56″Placebo′n = 54″
 
Table 1. Measurements before and after taking test granules. (Pan et al., 2011a)  
 
Group Time
 Non-fluent
speech
 Vertigo
 Insomnia/
nightmare
Headache
Sweating or
night sweats
Tiredness
Sense of
cold
Dysuria
week 0 1.08 ± 0.74 1.33 ± 0.83 2.77 ± 0.98 0.92 ± 0.56 2.11 ± 0.68 1.66 ± 0.57 1.90 ± 0.67 2.23 ± 0.69
TCM week 1 0.56 ± 0.28* 0.84 ± 0.26* #  2.03 ± 0.78* 0.64 ± 0.28* ## 1.38 ± 0.69*  # 1.21 ± 0.46* 1.48 ± 0.57* 1.43 ± 0.31* #
week 13 0.65 ± 0.33* ## 0.95 ± 0.37* 1.73 ± 0.38* # 0.63  ±0.19* # 1.48 ± 0.28* ## 1.27 ± 0.51* # 1.58 ± 0.61 1.46 ± 0.36* ##
 week 0 1.12 ± 0.59 1.31 ± 0.97 2.67 ± 0.87 1.03 ± 0.75 2.13 ± 1.32 1.70 ± 0.97 1.78 ± 0.39 2.29 ± 1.02
Placebo week 1 0.69 ± 0.32* 1.12 ± 0.69 2.40 ± 0.69* 0.96 ± 0.36* 1.87 ± 0.58 1.35 ± 0.69* 1.39 ± 0.81 1.69 ± 0.92*
week 13 1.02 ± 0.36 1.28 ± 0.53 2.45 ± 0.38 0.99 ± 0.65 2.18 ± 0.56 1.58 ± 0.66 1.64 ± 0.58 2.18 ± 1.30
Data presented are mean ± SD.*: P < 0.05, **: P < 0.01 compared with 0 weeks (Repeated-measure ANOVAs).
#:P < 0.05, ##:P < 0.01 compared to placebo (Bonferroni test).  
Table 2. Secondary symptom scores before and after taking test granules. (Pan et al., 2011a)  
with idiopathic PD who had at least three awakenings per night occurring at least 3 nights 
per week participated. Patients wore the actigraph on the wrist of their non-dominant hand 
for seven consecutive days twice at week 0 (before) and week 6 of taking either one of the 
granule. For control, age-matched 25 patients with non-neurological diseases who had 
neither sleep disturbance nor parkinsonism wore the actigraph for seven consecutive days. 
Daily profiles of activity counts clearly demonstrated an improvement of the biological 
rhythm after the additional treatment in the TCM group but not in the placebo group (Fig. 
6A). After treatment, sleep latency, median sleep efficiency and the median 5 least active 
hour, all of which were the parameters specifically reflected sleep disturbance (Pan et al., 
2011b), shifted towards the values of the control group in the TCM group, but not in the 
placebo group (Fig 6B).  
Scores in UPDRS Part II reflects the long-term outcome of the patients (Harrison et al., 2009). 
That both -values for local maxima and the scores in UPDRS Part II, Part II + Part III and 
Part IV improved after TCM suggested that -values for local maxima reflected patients’ 
overall ADL, including motor symptoms and non-motor symptoms. Therefore, it is likely 
that analysis of the α-values is useful for the evaluation of drug effects on the long-term 
outcome of patient with PD (Pan et al., 2011a; 2011b). 
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Fig. 6. Effects of cerebral granule (TCM). (A) Daily profiles of actigraph count for three 
consecutive days before and after taking TCM. Dashed line: midnight. (B) Changes from 
baseline in actigraph counts. Columns and bars (mean ± S.D.) indicate sleep efficiency (%), 
sleep latency (min) and the 5 least active hours (counts/min). *: p < 0.05; **: p < 0.01. 
Reprinted with permission from (Pan et al., 2011b). 
5. Assessment for effects of GVS for ameliorating parkinsonism 
Enhancing neuronal transmission is a possible non-pharmacological therapeutic strategy for 
neurological diseases. The cranial nerves send direct inputs to the brain, and their 
stimulation may lead to alterations in various central functions. Such stimulation may 
potentially be a therapeutic strategy for brain disorders due to the low invasiveness as 
compared to deep brain stimulation. Considering its central connections, the vestibular 
nerve can influence limbic-to-motor functions, and we applied non-invasive and non-
nociceptive noisy galvanic vestibular stimulation (GVS) to the patients with parkinsonism. 
We successfully improved parkinsonian symptoms by using noisy GVS at a low-frequency 
range targeting the vestibular nerves of patients with levodopa responsive PD and levodopa 
unresponsive parkinsonism (Yamamoto et al., 2005). This effect is presumably through the 
demonstrated vestibule-cerebellar connections, and input noise played the beneficial role in 
sensitizing neural systems, possibly through a mechanism known as stochastic resonance, a 
basic physical mechanism underlying noise-enhanced responses of nonlinear systems to 
weak signals. It is hypothesized that a central circuit signaling the onset of movement of 
which the threshold is relatively increased due to the diseases may benefit from noisy 
emulation of the afferent firing rates. We analyzed whether the beneficial effects of GVS on 
parkinsonism was reflected in a decrease of the -value for local maxima. 
As previously described (Yamamoto et al., 2005), a portable GVS device was used to deliver 
currents using a bilateral unipolar configuration, in which electrodes were placed over the 
patient’s bilateral mastoid processes with the reference electrodes placed on the forehead. 
The waveform, a zero-mean, linearly detrended noisy current with a 1/f-type power 
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spectrum (Struzik et al., 2006) within a range of 0.01-2.0 Hz or a constant zero current for 
control, with a duration of 300 sec was continuously repeated during the tests. The 
magnitude of noisy GVS was set to 60% of each subject’s nociceptive threshold (0.29 ± 0.20 
mA). Then either the noisy GVS or the control zero current was continuously applied for the 
first 24 hours, and then switched to the counter-part and applied for another 24 hours, while 
the patients’ wrist activity was monitored continuously for 48 hours. The order of noisy GVS 
and the control zero current was determined for each patient by random selection. 
 
 
Fig. 7. Illustrative examples of wrist activity data of a PD patient during the control (CON) 
period (A) and during GVS application (B). The wavelet coefficients (W(S)) of these data, as 
a function of the wavelet scale (S) are shown for local maxima (C) and minima (D). The 
slopes are power-law exponents . Reprinted with permission from (Pan et al., 2008). 
The representative wrist activity data of a PD patient during the control period and during 
the application of GVS were shown in Fig. 7A, B. Compared to control, GVS was associated 
with more frequent switching between higher and lower levels of activity. This resulted in a 
higher wavelet power (W(S)2) with GVS (Fig. 7C, D), particularly at smaller scales (S), or 
higher frequencies, for local maxima (Fig.7C). The power-law exponent , given by the slope 
of the log S vs. Log W(S)2 relationship and characterizing the nature of switching patterns 
between high and low values in a statistical sense, was smaller with GVS than with control 
stimulation, especially for the local maxima (Fig. 7C,D). 
The group average wavelet coefficients exhibited linear relationships in the range of scales 
(S) from 8 min to 35 min both for local maxima and minima and for GVS and control 
conditions (Fig. 8A, B). The slope for local maxima with noisy GVS was substantially less 
than that with control stimulation. For local maxima, the mean power-law exponent was 
significantly smaller for GVS than for the control (Fig. 8C). The difference in the mean  for 
local minima was much less than that for the local maxima. When the mean -values for the 
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Fig. 8. The group average wavelet coefficients for local maxima (A) and minima (B) for GVS 
and control (CON) conditions. (C) Comparisons of the mean  for GVS and CON (left) and 
the within-individual differences (right). The error bars represent SEM. Reprinted with 
permission from (Pan et al., 2008). 
first and the second days were compared, significant differences were not observed either 
for local maxima or minima, suggesting that the above differences were due to the GVS 
application itself, not to an order effect. 
We confirmed that measurement of the mean  for local maxima detected the improvement 
of parkinsonism during GVS with sufficient sensitivity (Pan et al., 2008).  
6. Conclusion 
Analysis of patients’ physical activity records collected by an actigraph device using power-
law exponents probing temporal autocorrelation of the activity counts provides methods for 
the evaluation of disability resulting from motor and non-motor parkinsonism without 
being influenced by the presence of tremor or different patterns of daily living (Pan et al., 
2007). Sufficient sensitivity and reliability of this method warrants the objectivity in the 
evaluation of symptom severity (Pan et al., 2008; Pan et al., 2011a) , hence this method may 
be useful for the evaluation of disease progression and efficacy of new drug. 
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